Society of Utah Medical Oncology

Welcome

Our primary mission is to promote the highest professional standards of oncology practice in the state of Utah; to study, research and exchange information, leading to improvement in the practice of hematology; to support and further oncology education; and to monitor and respond to appropriate legislative and regulatory concerns of the membership.

We encourage all oncology professionals to find out more about us and become a member of our growing community.

Tweets by SUMOncology

Membership has its benefits. Click below to find out more.

Join Today

COVID-19 News and Information - Frequently Updated!

Click here for information, resources, and programs related to the COVID-19 coronavirus.

CORONAVIRUS INFORMATION FROM THE CDC
CDC is working across the Department of Health and Human Services and across the U.S. government in the public health response to COVID-19.
Please see links below for additional information:

IMPORTANT INFORMATION FOR ALL PROVIDERS
FROM THE AMERICAN MEDICAL ASSOCIATION

As of January 1, 2021, there will be significant changes to the office and outpatient Evaluation and Management (E&M) services (CPT ® codes 99202-99215) for both new and established patients.

Find out more

Upcoming Events

As you are aware, we are facing uncertain times with the emergence of the COVID-19 virus. There is nothing more important to us than the safety and well-being of our attendees’ and the patients they serve.

After discussion amongst our board, we believe the best option moving forward is postponing the April 21 Spring Meeting. A rescheduled date will be selected soon but may remain tentative based on COVID-19 restrictions. We realize this may cause some inconvenience to you and we sincerely apologize!

Looking ahead, we are hopeful you'll still be able to join us. As it becomes available, additional information will be posted on the website. We appreciate your understanding as we navigate these unique circumstances.

Stay healthy and safe,

Carol Christner
Executive Director
Society of Utah Medical Oncologists

More Events:

Current news

March 20, 2020 - Federal Probe Into China Ties at U.S. Institutions May Affect Blameless Researchers, Find out more
March 20, 2020 - Trump’s Plan to Import Canadian Drugs Faces Continuing Opposition, Find out more
March 9, 2020 - Juul Labs Sought to Court AGs as Teen Vaping Surged, Find out more
March 3, 2020 - Community Oncology Files Amicus Brief with Supreme Court Supporting State Regulation of PBMs, Find out more
March 2, 2020 - The Association Between Drug Rebates and List Prices, Find out more

Corporate Partners

Quick Links

Upcoming Events

Tue Apr 21, 2020Spring Business Meeting - POSTPONED

Category: Events

Thu Apr 23, 2020Community Oncology Conference - VIRTUAL!

Category: Events

Sat Jun 27, 2020 SUMO 2020 Update in Oncology: Highlights from ASCO

Category: Events

Fri Jul 10, 2020Board Planning Meeting

Category: Events

Sat Sep 19, 2020Fall Clinical Meeting

Category: Events

View Full Calendar

Announcements

Open Payments: Review and Dispute Process Open April 1
On April 1, 2020, the review, dispute, and correction process for the Open Payments Program for program year 2019 will open. Physicians and teaching hospitals may review and dispute any updated records attributed to them by reporting entities until May 15.

Find out more

ASCO Annual Meeting To Go Virtual
As public health safety measures related to COVID-19 extend, the ASCO Board has concluded that the Annual Meeting, scheduled for May 29-June 2 in Chicago, cannot occur in person as planned. Our mission is as important as ever. That is why we still intend to deliver the latest cancer science to the global community during the Annual Meeting timeframe using a virtual format.

Find out more

On February 18, 106 organizations representing patients, providers, medical researchers, survivors, and families joined together to urge Congress to include the bipartisan CLINICAL TREATMENT Act (H.R. 913) in the upcoming ‘must pass’ healthcare extenders package, which is expected to pass this spring.